Dow Down 0.52% Nasdaq Down 1.33%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.36 Down 0.41(8.60%) 2:22PM EDT - Nasdaq Real Time Price
Prev Close:4.77
Open:4.71
Bid:4.32 x 79600
Ask:4.33 x 7500
1y Target Est:11.00
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.32 - 4.72
52wk Range:4.32 - 7.82
Volume:4,639,913
Avg Vol (3m):3,660,280
Market Cap:534.24M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 8.60%534.24M
ABTDown 0.62%65.14B
GSKDown 0.46%113.28B
RHHBYUp 0.07%255.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):170.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback